1.Hendrix, N, Berghella, V. Non-placental causes of intrauterine growth restriction. Semin Perinatol. 2008; 32, 161–165.
2.Reinehr, T, Kleber, M, Toschke, AM. Small for gestational age status is associated with metabolic syndrome in overweight children. Eur J Endocrinol. 2009; 160, 579–584.
3.Reinehr, T, Kleber, M, Toschke, AM. Former small for gestational age (SGA) status is associated to changes of insulin resistance in obese children during weight loss. Pediatr Diabetes. 2010; 11, 431–437.
4.Gatford, KL, Simmons, RA, De Blasio, MJ, Robinson, JS, Owens, JA. Review: placental programming of postnatal diabetes and impaired insulin action after IUGR. Placenta. 2010; 31, S60–S65.
5.Barker, DJ, Hales, CN, Fall, CH, et al.Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993; 36, 62–67.
6.Regnault, TR, Galan, HL, Parker, TA, Anthony, RV. Placental development in normal and compromised pregnancies. Placenta. 2002; 23(Suppl. A), S119–S129.
7.Regnault, TR, Orbus, RJ, de Vrijer, B, et al.Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). Placenta. 2002; 23, 132–144.
8.Limesand, SW, Regnault, TR, Hay, WW Jr. Characterization of glucose transporter 8 (GLUT8) in the ovine placenta of normal and growth restricted fetuses. Placenta. 2004; 25, 70–77.
9.de Vrijer, B, Regnault, TR, Wilkening, RB, Meschia, G, Battaglia, FC. Placental uptake and transport of ACP, a neutral nonmetabolizable amino acid, in an ovine model of fetal growth restriction. Am J Physiol Endocrinol Metab. 2004; 287, E1114–E1124.
10.Leos, RA, Anderson, MJ, Chen, X, et al.Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction. Am J Physiol Endocrinol Metab. 2010; 298, E770–E778.
11.Limesand, SW, Hay, WW Jr. Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction. J Physiol. 2003; 547, 95–105.
12.Jackson, BT, Piasecki, GJ, Cohn, HE, Cohen, WR. Control of fetal insulin secretion. Am J Physiol Regul Integr Comp Physiol. 2000; 279, R2179–R2188.
13.Harwell, CM, Padbury, JF, Anand, RS, et al.Fetal catecholamine responses to maternal hypoglycemia. Am J Physiol. 1990; 259, R1126–R1130.
14.de, VB, Davidsen, ML, Wilkening, RB, Anthony, RV, Regnault, TR. Altered placental and fetal expression of IGFs and IGF-binding proteins associated with intrauterine growth restriction in fetal sheep during early and mid-pregnancy. Pediatr Res. 2006; 60, 507–512.
15.Galan, HL, Hussey, MJ, Barbera, A, et al.Relationship of fetal growth to duration of heat stress in an ovine model of placental insufficiency. Am J Obstet Gynecol. 1999; 180, 1278–1282.
16.Fowden, AL. The role of insulin in fetal growth. Early Hum Dev. 1992; 29, 177–181.
17.Limesand, SW, Rozance, PJ, Smith, D, Hay, WW Jr. Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction. Am J Physiol Endocrinol Metab. 2007; 293, E1716–E1725.
18.Sperling, MA, Christensen, RA, Ganguli, S, Anand, R. Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep. Pediatr Res. 1980; 14, 203–208.
19.Rychkov, GY, Adams, MB, McMillen, IC, Roberts, ML. Oxygen-sensing mechanisms are present in the chromaffin cells of the sheep adrenal medulla before birth. J Physiol. 1998; 509, 887–893.
20.Yates, DT, Macko, AR, Chen, X, et al.Hypoxemia-induced catecholamine secretion from adrenal chromaffin cells inhibits glucose-stimulated hyperinsulinemia in fetal sheep. J Physiol. 2012; 590, 5439–5447.
21.Bassett, JM. Metabolic effects of catecholamines in sheep. Aust J Biol Sci. 1970; 23, 903–914.
22.Bassett, JM, Hanson, C. Catecholamines inhibit growth in fetal sheep in the absence of hypoxemia. Am J Physiol. 1998; 274, R1536–R1545.
23.Sperling, MA, Ganguli, S, Leslie, N, Landt, K. Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. Am J Physiol. 1984; 247, E69–E74.
24.Yates, DT, Macko, AR, Nearing, M, et al.Developmental programming in response to intrauterine growth restriction impairs myoblast function and skeletal muscle metabolism. J Pregnancy. 2012; 2012:631038. doi: 10.1155/2012/631038.
25.Chen, X, Fahy, AL, Green, AS, et al.Beta2-adrenergic receptor desensitization in perirenal adipose tissue in fetuses and lambs with placental insufficiency-induced intrauterine growth restriction. J Physiol. 2010; 588, 3539–3549.
26.Yates, DT, Green, AS, Limesand, SW. Catecholamines mediate multiple fetal adaptations during placental insufficiency that contribute to intrauterine growth restriction: lessons from hyperthermic sheep. J Pregnancy. 2011; 2011:740408. doi: 10.1155/2011/740408.
27.Green, AS, Rozance, PJ, Limesand, SW. Consequences of a compromised intrauterine environment on islet function. J Endocrinol. 2010; 205, 211–224.
28.Limesand, SW, Rozance, PJ, Zerbe, GO, Hutton, JC, Hay, WW Jr. Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction. Endocrinology. 2006; 147, 1488–1497.
29.Greenough, A, Nicolaides, KH, Lagercrantz, H. Human fetal sympathoadrenal responsiveness. Early Hum Dev. 1990; 23, 9–13.
30.Lagercrantz, H, Sjoquist, B, Bremme, K, Lunell, NO, Somell, C. Catecholamine metabolites in amniotic fluid as indicators of intrauterine stress. Am J Obstet Gynecol. 1980; 136, 1067–1070.
31.Okamura, K, Watanabe, T, Tanigawara, S, et al.Biochemical evaluation of fetus with hypoxia caused by severe preeclampsia using cordocentesis. J Perinat Med. 1990; 18, 441–447.
32.Pardi, G, Cetin, I, Marconi, AM, et al.Venous drainage of the human uterus: respiratory gas studies in normal and fetal growth-retarded pregnancies. Am J Obstet Gynecol. 1992; 166, 699–706.
33.Limesand, SW, Rozance, PJ, Macko, AR, et al.Reductions in insulin concentrations and beta-cell mass precede growth restriction in sheep fetuses with placental insufficiency. Am J Physiol Endocrinol Metab. 2013; 304, E516–E523.
34.Regnault, TR, Orbus, RJ, Battaglia, FC, Wilkening, RB, Anthony, RV. Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency. J Endocrinol. 1999; 162, 433–442.
35.Limesand, SW, Jensen, J, Hutton, JC, Hay, WW Jr. Diminished β-cell replication contributes to reduced β-cell mass in fetal sheep with intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R1297–R1305.
36.Green, AS, Chen, X, Macko, AR, et al.Chronic pulsatile hyperglycemia reduces insulin secretion and increases accumulation of reactive oxygen species in fetal sheep islets. J Endocrinol. 2012; 212, 327–342.
37.Regnault, TR, Orbus, RJ, Battaglia, FC, Wilkening, RB, Anthony, RV. Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency. J Endocrinol. 1999; 162, 433–442.
38.Green, AS, Macko, AR, Rozance, PJ, et al.Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus. Am J Physiol Endocrinol Metab. 2011; 300, E817–E823.
39.Cheung, CY. Fetal adrenal medulla catecholamine response to hypoxia-direct and neural components. Am J Physiol. 1990; 258, R1340–R1346.
40.Comline, RS, Silver, M. The development of the adrenal medulla of the foetal and new-born calf. J Physiol. 1966; 183, 305–340.
41.Padbury, JF, Ludlow, JK, Ervin, MG, Jacobs, HC, Humme, JA. Thresholds for physiological effects of plasma catecholamines in fetal sheep. Am J Physiol. 1987; 252, E530–E537.
42.Yates, DT, Macko, AR, Chen, X, et al.Hypoxemia-induced catecholamine secretion from adrenal chromaffin cells inhibits glucose-stimulated hyperinsulinemia in fetal sheep. J Physiol. 2012; 590, 5439–5447.
43.Kawai, K, Yokota, C, Ohashi, S, Watanabe, Y, Yamashita, K. Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia. 1995; 38, 274–276.
44.Robertson, RP. Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes. 2007; 56, 2420–2424.
45.Hermans, MP, Schmeer, W, Henquin, JC. The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse islets. Diabetologia. 1987; 30, 659–665.
46.Schmidt, C, Bladt, F, Goedecke, S, et al.Scatter factor/hepatocytes growth factor is essential for liver development. Nature. 1995; 373, 699–702.
47.Thorn, SR, Regnault, TR, Brown, LD, et al.Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscle. Endocrinology. 2009; 150, 3021–3030.
48.Owens, JA, Falconer, J, Robinson, JS. Glucose metabolism in pregnant sheep when placental growth is restricted. Am J Physiol. 1989; 257, R350–R357.
49.Owens, JA, Gatford, KL, De Blasio, MJ, et al.Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth. J Physiol. 2007; 584, 935–949.
50.Deibert, DC, DeFronzo, RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980; 65, 717–721.
51.Brown, LD, Rozance, PJ, Thorn, SR, Friedman, JE, Hay, WW Jr. Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep. Am J Physiol Endocrinol Metab. 2012; 303, E352–E364.